Skip to main content
Livermore
Livermore
ZHEN

Zynerba Pharmaceuticals, Inc.

ZYNEDelisted Oct 11, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001621443

Zynerba Pharmaceuticals, Inc. was delisted on Oct 11, 2023; its insiders filed their last Form 4 on Oct 11, 2023; 43 institutions reported holding it in 13F filings for Q3 2023, worth $14.7M in total; no superinvestor held it.

13F holders, Q3 2023

Institutional positions in Zynerba Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

ZYNE is no longer listed, so this page shows Q3 2023. 13F filings for later quarters list far fewer holders.

Institutional holders
43
+3 vs. Q2 2023
Shares held
11.5M
+6.17M (+115.7%) vs. Q2 2023
Total value
$14.7M
+$13.0M (+746.7%) vs. Q2 2023
New holders
17
3 more added
Sold out
14
11 more reduced

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ZYNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 43 institutions
Q1 2021: 67 institutionsQ2 2021: 65 institutionsQ3 2021: 59 institutionsQ4 2021: 62 institutionsQ1 2022: 59 institutionsQ2 2022: 56 institutionsQ3 2022: 62 institutionsQ4 2022: 50 institutionsQ1 2023: 44 institutionsQ2 2023: 41 institutionsQ3 2023: 43 institutionsQ4 2023: 0 institutionsQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2023: $14.7M
Q1 2021: $42.1MQ2 2021: $78.1MQ3 2021: $57.1MQ4 2021: $38.3MQ1 2022: $24.8MQ2 2022: $12.5MQ3 2022: $7.97MQ4 2022: $4.23MQ1 2023: $2.75MQ2 2023: $1.74MQ3 2023: $14.7MQ4 2023: $0Q1 2024: $16.2KQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ZYNE and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$16.2K
Q4 20230$0
Q3 202343$14.7M
Q2 202341$1.74M
Q1 202344$2.75M
Q4 202250$4.23M
Q3 202262$7.97M
Q2 202256$12.5M
Q1 202259$24.8M
Q4 202162$38.3M
Q3 202159$57.1M
Q2 202165$78.1M
Q1 202167$42.1M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Zynerba Pharmaceuticals, Inc.; share changes are against Q2 2023.

Institutions holding ZYNE in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada315$00.00%−12,295−97.5%Reduced
Lindbrook Capital, LLC1$10.00%00.0%Unchanged
Iron Horse Wealth Management, LLC1$10.00%00.0%Unchanged
GHP Investment Advisors, Inc.1$20.00%00.0%Unchanged
HM Payson & Co50$640.00%00.0%Unchanged
Qube Research & Technologies Ltd100$1270.00%+100New
Harbour Investments, Inc.100$1280.00%00.0%Unchanged
Creative Planning100$1280.00%+100New
Bank of America Corp282$3600.00%+109+63.0%Added
Sound Income Strategies, LLC350$4450.00%00.0%Unchanged
Rhumbline Advisers805$1.02K0.00%00.0%Unchanged
Founders Capital Management2,000$2.54K0.00%00.0%Unchanged
Wells Fargo & Company2,464$3.14K0.00%−73,443−96.8%Reduced
Tower Research Capital LLC (TRC)2,814$3.59K0.00%−13,003−82.2%Reduced
Newbridge Financial Services Group, Inc.3,610$4.60K0.00%−1,000−21.7%Reduced
Key Financial Inc7,500$9.56K0.00%00.0%Unchanged
National Asset Management, Inc.12,732$16.2K0.00%+12,732New
Virtu Financial LLC13,098$17.0K0.00%+13,098New
King Wealth16,000$20.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.16,161$20.6K0.00%−20,949−56.5%Reduced
XTX Topco Ltd18,793$23.9K0.00%+18,793New
UBS Group AG20,385$26.0K0.00%−6,183−23.3%Reduced
JPMorgan Chase & Co20,875$26.5K0.00%+11,403+120.4%Added
Cetera Advisor Networks LLC22,124$28.2K0.00%−5,330−19.4%Reduced
Morgan Stanley34,783$44.3K0.00%−8,831−20.2%Reduced
Charles Schwab Investment Management Inc37,596$47.7K0.00%00.0%Unchanged
Geode Capital Management, LLC37,934$48.2K0.00%−349,412−90.2%Reduced
Northern Trust Corp46,072$58.7K0.00%−69,138−60.0%Reduced
Fifth Lane Capital, LP100,000$127.0K0.13%+100,000New
GTS Securities LLC120,121$152.6K0.00%+120,121New
PenderFund Capital Management Ltd.123,444$213.0K0.06%+123,444New
HRT Financial LP203,229$258.0K0.00%+203,229New
Penserra Capital Management LLC220,858$280.0K0.01%00.0%Unchanged
Susquehanna International Group, LLP221,719$281.6K0.00%+221,719New
Crystalline Management Inc.230,817$294.3K0.22%+230,817New
Jane Street Group, LLC282,478$360.2K0.00%+282,478New
Millennium Management LLC325,237$413.1K0.00%+199,402+158.5%Added
Deltec Asset Management LLC475,000$605.6K0.14%+475,000New
CSS LLC476,831$608.0K0.05%+476,831New
Renaissance Technologies LLC605,700$772.0K0.00%−84,013−12.2%Reduced
Yakira Capital Management, Inc.620,019$790.5K0.21%+620,019New
Highbridge Capital Management LLC2,283,979$2.91M0.16%+2,283,979New
Beryl Capital Management LLC4,898,927$6.25M0.79%+4,898,927New
Vanguard Group Inc0$00.00%−2,179,600−100.0%Sold out
BlackRock Inc.0$00.00%−740,524−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−124,000−100.0%Sold out
State Street Corp0$00.00%−119,741−100.0%Sold out
Bernardo Wealth Planning LLC0$00.00%−78,578−100.0%Sold out
Two Sigma Investments, LP0$00.00%−70,163−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−65,900−100.0%Sold out
Sequoia Financial Advisors, LLC0$00.00%−49,700−100.0%Sold out
Bank of New York Mellon Corp0$00.00%−26,311−100.0%Sold out
Raymond James Financial Services Advisors, Inc.0$00.00%−13,900−100.0%Sold out
TD Waterhouse Canada Inc.0$00.00%−4,145−100.0%Sold out
Group One Trading, L.P.0$00.00%−4,559−100.0%Sold out
FMR LLC0$00.00%−25−100.0%Sold out
IFP Advisors, Inc0$00.00%−23−100.0%Sold out
Kistler-Tiffany Companies, LLC––––Not filed